| Serial Number | 88660331 |
| Word Mark | CBD 2.0 |
| Filing Date | Friday, October 18, 2019 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Tuesday, May 25, 2021 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical preparation for skin care; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for skin care; Pharmaceutical preparations for skin wounds; Pharmaceutical preparations for the prevention of chemotherapy induced peripheral neuropathy, neurodegeneration, oxidative stress related diseases and disorders, neuropathic pain, and atopic dermatitis; Pharmaceutical preparations for the treatment and prevention of chemotherapy induced peripheral neuropathy, neurodegeneration, oxidative stress related diseases and disorders, neuropathic pain, and atopic dermatitis; Pharmaceutical preparations for the treatment of musculo-skeletal disorders; Pharmaceutical preparations for the treatment of chemotherapy induced peripheral neuropathy, neurodegeneration, oxidative stress related diseases and disorders, neuropathic pain, and atopic dermatitis; Pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for treating sunburn; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Pharmaceutical products for the treatment of joint disease; Pharmaceutical skin lotions; Dermatological pharmaceutical products; Extracts of hops for pharmaceutical purposes; Frostbite salve for pharmaceutical purposes; Phenol for pharmaceutical purposes; Plant extracts for pharmaceutical purposes |
| Pseudo Mark | CBD TWO POINT ZERO |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, October 22, 2019 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Kannalife, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Doylestown, PA 18902 |
| Event Date | Event Description |
| Wednesday, May 26, 2021 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| Tuesday, May 25, 2021 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Monday, May 24, 2021 | ASSIGNED TO EXAMINER |
| Tuesday, October 27, 2020 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, October 27, 2020 | NON-FINAL ACTION E-MAILED |
| Tuesday, October 27, 2020 | NON-FINAL ACTION WRITTEN |
| Thursday, September 3, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, September 2, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, September 2, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, April 30, 2020 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, April 30, 2020 | NON-FINAL ACTION E-MAILED |
| Thursday, April 30, 2020 | NON-FINAL ACTION WRITTEN |
| Monday, April 27, 2020 | ASSIGNED TO EXAMINER |
| Sunday, November 10, 2019 | ASSIGNED TO EXAMINER |
| Tuesday, October 22, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |